EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang‐Cheol Bae, John Boletis, Ian N Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, Richard Furie, Dafna D. Gladman, Frédéric Houssiau, Luís Inês, David Jayne, Marios Kouloumas, László Kovács, Chi Chiu Mok, Eric F. Morand, Gabriella Moroni, Marta Mosca, Johanna Mücke, Chetan Mukhtyar, György Nagy, Sandra Navarra, Ioannis Parodis, José María Pego‐Reigosa, Michelle Petri, Bernardo A. Pons‐Estel, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y K Onno Teng, Anǵela Tincani, Edward M Vital, Ronald van Vollenhoven, Chris Wincup, George Βertsias, Dimitrios T. Boumpas
Topics & Concepts
MedicineBelimumabAzathioprineRituximabHydroxychloroquineLupus nephritisNintedanibEfalizumabSystemic lupus erythematosusAbataceptPrednisoneMaintenance therapyInternal medicineIntensive care medicineImmunologyDiseaseInfliximabIdiopathic pulmonary fibrosisB-cell activating factorLungLymphomaChemotherapyAntibodyCoronavirus disease 2019 (COVID-19)B cellInfectious disease (medical specialty)Systemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesSystemic Sclerosis and Related Diseases